Update

The tech firm has been a critical conduit for shuttling information between most of the nation's insurance companies and providers, but since the hack, some insurers must send forms in the mail, delaying payment substantially.

In a recent speech, President Biden overstated the average monthly cost that patients were paying prior to the Inflation Reduction Act: The out-of-pocket cost for insulin was $58 for a 30-day supply, says a HHS report.

More patients are losing their doctors — and trust in the primary care system, according to American Medical Association's president, Jesse Ehrenfeld.

The savings are not yet realized, says the Congressional Budget Office, which projects a 10-year cumulative savings of $161 billion from the phased-in drug negotiation, as well as a rebate for price increases above the inflation rate.

The HHS rule, which mandates that health insurers not count copay assistance toward out-of-pocket costs, was struck down last fall, however, it is backfiring on patients with chronic diseases that need expensive drugs.

With increased government scrutiny on telehealth and potential changes to COVID-era telehealth flexibilities on the horizon, it is critical that companies keep apprised of telehealth compliance regulations through 2024 and beyond.

The RDS program has been the go-to choice for plan sponsors who offer group coverage to retired employees, however, the Inflation Reduction Act makes it difficult now for plans to meet the creditable qualification criteria.

Biden is counting on outrage over abortion restrictions to help drive turnout for his reelection, while Trump is promising to repeal Obamacare, but where do the candidates stand on Americans' everyday health concerns?